This is the authors' abstract. We don't add key points for this paper.
Porphyrins' unique structure confers exceptional light-interacting properties, driving interest in their use in medical therapies. This work investigates synthetic β-chalcone-substituted tetraphenylporphyrins derivatives using fluorescence-based methods to evaluate fluorescence, triplet formation, and internal conversion quantum yields, as well as fluorescence lifetimes, thereby revealing radiative and non-radiative decay rates. Two-photon absorption cross-sections were measured via the double-pulse induced fluorescence technique. Results highlight the tetraphenylporphyrin-chalcone interaction, with triplet-formation quantum yields of around 30% and internal-conversion yields up to 86%. Combined with short fluorescence lifetimes of no more than 10 ns, the decay rates suggest strong potential for photodynamic (PDT) and photothermal (PTT) therapies. Notably, the CP3 derivative bearing a high-electron-withdrawing nitrophenyl moiety increased the internal conversion rate to 360 × 10 6 s −1 , thereby demonstrating its photothermal therapy potential. The set also shows an increase in two-photon absorption, achieving up to 48 GM within the first biological window for CP1 and CP5, which could be useful for deeper tissue penetration in medical applications.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Nascimento et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: